Cited by 30

The DOI matches its Crossref record.

Comparison of RNA Editing Activity of APOBEC1-A1CF and APOBEC1-RBM47 Complexes Reconstituted in HEK293T Cells

Wolfe, Aaron D., Arnold, Don B., Chen, Xiaojiang S.·2019·Journal of Molecular Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jmb.2019.02.025

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 53

  1. Gagnidze, 2018, A new chapter in genetic medicine: RNA editing and its role in disease pathogenesis, Trends Mol. Med., 24, 294, 10.1016/j.molmed.2018.01.002 · DOI
  2. Mingardi, 2018, miRNA editing: new insights into the fast control of gene expression in health and disease, Mol. Neurobiol., 55, 7717, 10.1007/s12035-018-0951-x · DOI
  3. Qi, 2014, RNA Editome imbalance in hepatocellular carcinoma, Cancer Res., 74, 1301, 10.1158/0008-5472.CAN-13-3485 · DOI
  4. Thomas, 2017, How do ADARs bind RNA? New protein–RNA structures illuminate substrate recognition by the RNA editing ADARs, BioEssays., 39, 10.1002/bies.201600187 · DOI
  5. Vu, 2017, C-to-U editing and site-directed RNA editing for the correction of genetic mutations, Biosci. Trends, 11, 243, 10.5582/bst.2017.01049 · DOI
  6. Driscoll, 1989, An in vitro system for the editing of apolipoprotein B mRNA, Cell, 58, 519, 10.1016/0092-8674(89)90432-7 · DOI · Paper page
  7. Chen, 1987, Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon, Science, 238, 363, 10.1126/science.3659919 · DOI
  8. Powell, 1987, A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine, Cell, 50, 831, 10.1016/0092-8674(87)90510-1 · DOI
  9. Hirano, 1996, Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48, J. Biol. Chem., 271, 9887, 10.1074/jbc.271.17.9887 · DOI
  10. Nakamuta, 1996, Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of apobec-1, J. Biol. Chem., 271, 25981, 10.1074/jbc.271.42.25981 · DOI
  11. Teng, 1993, Molecular cloning of an apolipoprotein B messenger RNA editing protein, Science, 260, 1816, 10.1126/science.8511591 · DOI · Paper page
  12. Teng, 1999, Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). Structure–function relationships of RNA editing and dimerization, J. Lipid Res., 40, 623, 10.1016/S0022-2275(20)32141-6 · DOI
  13. Salter, 2016, The APOBEC protein family: united by structure, divergent in function, Trends Biochem. Sci., 41, 578, 10.1016/j.tibs.2016.05.001 · DOI · Paper page
  14. Harris, 2004, Retroviral restriction by APOBEC proteins, Nat. Rev. Immunol., 4, 868, 10.1038/nri1489 · DOI
  15. Swanton, 2015, APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity, Cancer Discov., 5, 704, 10.1158/2159-8290.CD-15-0344 · DOI
  16. Anant, 2002, Identification and regulation of protein components of the apolipoprotein B mRNA editing enzyme. A complex event, Trends Cardiovasc. Med., 12, 311, 10.1016/S1050-1738(02)00180-9 · DOI
  17. Lellek, 2000, Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex, J. Biol. Chem., 275, 19848, 10.1074/jbc.M001786200 · DOI · Paper page
  18. Mehta, 2002, Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing, RNA, 8, 69, 10.1017/S1355838202015649 · DOI
  19. Sowden, 1996, Determinants involved in regulating the proportion of edited apolipoprotein B RNAs, RNA, 2, 274
  20. Chester, 2003, The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay, EMBO J., 22, 3971, 10.1093/emboj/cdg369 · DOI
  21. Fossat, 2014, C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47, EMBO Rep., 15, 903, 10.15252/embr.201438450 · DOI · Paper page
  22. Snyder, 2017, APOBEC1 complementation factor (A1CF) is not required for C-to-U RNA editing in vivo, RNA, 10.1261/rna.058818.116 · DOI
  23. Rayon-Estrada, 2017, Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function, Proc. Natl. Acad. Sci. U. S. A., 114, 13296, 10.1073/pnas.1714227114 · DOI
  24. Blanc, 2014, Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver, Genome Biol., 15, 1, 10.1186/gb-2014-15-6-r79 · DOI
  25. Rosenberg, 2011, Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3′ UTRs, Nat. Struct. Mol. Biol., 18, 230, 10.1038/nsmb.1975 · DOI · Paper page
  26. Cole, 2017, Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology, Proc. Natl. Acad. Sci. U. S. A., 114, 13272, 10.1073/pnas.1710493114 · DOI
  27. Blanc, 2018, APOBEC1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver, RNA
  28. Gommans, 2010, A mammalian reporter system for fast and quantitative detection of intracellular A-to-I RNA editing levels, Anal. Biochem., 399, 230, 10.1016/j.ab.2009.12.037 · DOI
  29. Reenan, 2005, Molecular determinants and guided evolution of species-specific RNA editing, Nature, 434, 409, 10.1038/nature03364 · DOI
  30. Wang, 2018, Selective recognition of RNA substrates by ADAR deaminase domains, Biochemistry, 57, 1640, 10.1021/acs.biochem.7b01100 · DOI
  31. Kankowski, 2018, A novel RNA Editing sensor tool and a specific agonist determine neuronal protein expression of RNA-edited glycine receptors and identify a genomic APOBEC1 dimorphism as a new genetic risk factor of epilepsy, Front. Mol. Neurosci., 10, 1, 10.3389/fnmol.2017.00439 · DOI
  32. Severi, 2015, Flow-cytometric visualization of C > U mRNA editing reveals the dynamics of the process in live cells, RNA Biol., 12, 389, 10.1080/15476286.2015.1026033 · DOI
  33. Kilgard, 1995, Improved Green Fluorescence, Nature, 663, 10.1038/373663a0 · DOI
  34. Di Ventura, 2016, Go in! Go out! Inducible control of nuclear localization, Curr. Opin. Chem. Biol., 34, 62, 10.1016/j.cbpa.2016.06.009 · DOI
  35. Henderson, 2000, A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals, Exp. Cell Res., 256, 213, 10.1006/excr.2000.4825 · DOI
  36. Lange, 2007, Classical nuclear localization signals: definition, function, and interaction with importin α, J. Biol. Chem., 282, 5101, 10.1074/jbc.R600026200 · DOI
  37. Shaner, 2004, Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein, Nat. Biotechnol., 22, 1567, 10.1038/nbt1037 · DOI · Paper page
  38. Liu, 2017, Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector, Sci. Rep., 7, 1
  39. Ryan, 1991, Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence, J. Gen. Virol., 72, 2727, 10.1099/0022-1317-72-11-2727 · DOI
  40. Maris, 2005, NMR structure of the apoB mRNA stem–loop and its interaction with the C to U editing APOBEC1 complementary factor, RNA, 11, 173, 10.1261/rna.7190705 · DOI · Paper page
  41. Smith, 1998, Analysis of protein complexes assembled on apolipoprotein B mRNA for mooring sequence-dependent RNA editing, Methods, 15, 27, 10.1006/meth.1998.0603 · DOI
  42. Blanc, 2001, Mutagenesis of Apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein–protein interaction with Apobec-1, and complementation of C to U RNA-editing activity, J. Biol. Chem., 276, 46386, 10.1074/jbc.M107654200 · DOI
  43. Galloway, 2010, APOBEC-1 complementation factor (ACF) forms RNA-dependent multimers, Biochem. Biophys. Res. Commun., 398, 38, 10.1016/j.bbrc.2010.06.021 · DOI
  44. Mathews, 2004, Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure, Proc. Natl. Acad. Sci., 101, 7287, 10.1073/pnas.0401799101 · DOI
  45. Reuter, 2010, RNAstructure: software for RNA secondary structure prediction and analysis, BMC Bioinformatics, 11, 129, 10.1186/1471-2105-11-129 · DOI
  46. Mukhopadhyay, 2002, C→U Editing of Neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme, Am. J. Hum. Genet., 70, 38, 10.1086/337952 · DOI
  47. Skuse, 1996, The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing, Nucleic Acids Res., 24, 478, 10.1093/nar/24.3.478 · DOI
  48. Goodman, 2011, ADAR proteins: structure and catalytic mechanism, Curr Top Microbiol Immunol, 1
  49. Nishikura, 2010, Functions and regulation of RNA editing by ADAR deaminases, Annu. Rev. Biochem., 79, 321, 10.1146/annurev-biochem-060208-105251 · DOI · Paper page
  50. Xiao, 2017, Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation, Nucleic Acids Res., 45, 7494, 10.1093/nar/gkx362 · DOI
  51. Okonechnikov, 2012, Unipro UGENE: a unified bioinformatics toolkit, Bioinformatics, 28, 1166, 10.1093/bioinformatics/bts091 · DOI
  52. Rueden, 2017, ImageJ2: ImageJ for the next generation of scientific image data, BMC Bioinformatics, 18, 1, 10.1186/s12859-017-1934-z · DOI
  53. Schindelin, 2012, Fiji: an open-source platform for biological-image analysis, Nat. Methods, 9, 676, 10.1038/nmeth.2019 · DOI · Paper page

Cited by

Sorted by citations

See all 30

Metadata

Authors
Wolfe, A. D., Arnold, D. B., & Chen, X. S.
Venue
Journal of Molecular Biology
Publisher
Elsevier BV
Published
2019-03
Volume
431
Issue
7
Pages
1506-1517
ISSN
0022-2836
Cited by
30
References
0
Language
en
Funders
National Institutes of Health (R01GM087986)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review